These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 28618289)

  • 21. Rapid point-of-care testing for HIV-1 during labor and delivery--Chicago, Illinois, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):866-8. PubMed ID: 12970619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions.
    Shrestha RK; Sansom SL; Farnham PG
    J Public Health Manag Pract; 2012; 18(3):259-67. PubMed ID: 22473119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution in testing technology enables some urban EDs to implement HIV screening at relatively low cost.
    ED Manag; 2011 Oct; 23(10):109-12. PubMed ID: 21972754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
    Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
    N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between turnaround time and cost of herpes simplex virus testing by cell culture and polymerase chain reaction from genital swabs.
    Saeed K; Pelosi E
    Int J STD AIDS; 2010 Apr; 21(4):298-9. PubMed ID: 20378906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of rapid HIV test kits on whole blood and development of rapid testing algorithm for voluntary testing and counseling centers in Ethiopia.
    Tegbaru B; Messele T; Wolday D; Meles PH; Tesema D; Birhanu H; Tesfaye G; Bond KB; Martin R; Rayfield MA; Wuhib T; Fekadu M
    Ethiop Med J; 2004 Oct; 42(4):267-76. PubMed ID: 16122118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.
    Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML
    Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to Stegmann s, et Al. [J. Clin. Virol. 47 (1) (2010) 79-81].
    Tan DH; Walmsley SL
    J Clin Virol; 2010 Mar; 47(3):297-8. PubMed ID: 20079687
    [No Abstract]   [Full Text] [Related]  

  • 29. Interpreting and implementing the 2006 CDC recommendations for HIV testing in health-care settings.
    Lyons MS; Lindsell CJ; Fichtenbaum CJ; Camargo CA
    Public Health Rep; 2007; 122(5):579-83. PubMed ID: 17877304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Operational feasibility of using whole blood in the rapid HIV testing algorithm of a resource-limited settings like Bangladesh.
    Munshi SU; Oyewale TO; Begum S; Uddin Z; Tabassum S
    Curr Opin HIV AIDS; 2016 Mar; 11 Suppl 1(Suppl 1):S13-20. PubMed ID: 26945143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical validation of a novel diagnostic HIV-2 total nucleic acid qualitative assay using the Abbott m2000 platform: Implications for complementary HIV-2 nucleic acid testing for the CDC 4th generation HIV diagnostic testing algorithm.
    Chang M; Wong AJ; Raugi DN; Smith RA; Seilie AM; Ortega JP; Bogusz KM; Sall F; Ba S; Seydi M; Gottlieb GS; Coombs RW
    J Clin Virol; 2017 Jan; 86():56-61. PubMed ID: 27951466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine HIV testing in dental practice: can we cross the Rubicon?
    Vernillo AT; Caplan AL
    J Dent Educ; 2007 Dec; 71(12):1534-9. PubMed ID: 18096878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of testing for human immunodeficiency virus.
    Bylund DJ; Ziegner UH; Hooper DG
    Clin Lab Med; 1992 Jun; 12(2):305-33. PubMed ID: 1611822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost effectiveness analysis of the New Jersey rapid testing algorithm for HIV testing in publicly funded testing sites.
    Stevinson K; Martin EG; Marcella S; Paul SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S29-33. PubMed ID: 22078147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High mortality in HIV-infected children diagnosed in hospital underscores need for faster diagnostic turnaround time in prevention of mother-to-child transmission of HIV (PMTCT) programs.
    Wagner A; Slyker J; Langat A; Inwani I; Adhiambo J; Benki-Nugent S; Tapia K; Njuguna I; Wamalwa D; John-Stewart G
    BMC Pediatr; 2015 Feb; 15():10. PubMed ID: 25886564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV testing updates and challenges: when regulatory caution and public health imperatives collide.
    Branson BM
    Curr HIV/AIDS Rep; 2015 Mar; 12(1):117-26. PubMed ID: 25656347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential efficiency of routine HIV testing of hospital patients--data from a CDC sentinel hospital.
    Henry K; Campbell S
    Public Health Rep; 1992; 107(2):138-41. PubMed ID: 1561293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation and improvement strategy of analytical turnaround time in the stat laboratory.
    Chien TI; Lu JY; Kao JT; Cheng YC; Lee YF
    J Formos Med Assoc; 2007 Jul; 106(7):558-64. PubMed ID: 17660145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of new HIV infections in a multicentre HIV antiretroviral pre-exposure prophylaxis trial.
    Fransen K; de Baetselier I; Rammutla E; Ahmed K; Owino F; Agingu W; Venter G; Deese J; Van Damme L; Crucitti T;
    J Clin Virol; 2017 Aug; 93():76-80. PubMed ID: 28351689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost-effectiveness of expanded HIV screening in the United States.
    Lucas A; Armbruster B
    AIDS; 2013 Mar; 27(5):795-801. PubMed ID: 23169333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.